NETCARE LIMITED AUDITED GROUP RESULTS FOR THE YEAR ENDED 30 SEPTEMBER 2016 CARE DIGNITY TRUTH PARTICIPATION PASSION

Size: px
Start display at page:

Download "NETCARE LIMITED AUDITED GROUP RESULTS FOR THE YEAR ENDED 30 SEPTEMBER 2016 CARE DIGNITY TRUTH PARTICIPATION PASSION"

Transcription

1 NETCARE LIMITED AUDITED GROUP RESULTS FOR THE YEAR ENDED 30 SEPTEMBER 2016

2 PRESENTATION OUTLINE Group Overview South Africa United Kingdom Financial Review Guidance

3 GROUP OVERVIEW

4 4 Group A comprehensive network of healthcare services Hospitals Hospital beds Primary healthcare centres¹ Retail pharmacies Renal dialysis facilities Netcare 911 sites Netcare training colleges Employees 1. Includes primary care clinics, day clinics and sub-acute facilities

5 5 Group Overview South Africa (SA) Good financial performance in line with guidance Integration of 584 new beds added in FY 2015 Competition Authority approval of retail pharmacy outsourcing to Clicks¹ Acquisition² of Akeso Clinics, a national network of 12 mental health facilities United Kingdom (UK) Solid trading performance Independent hospitals increasingly an integrated part of UK public health delivery Strong growth in NHS GP referrals Rent transaction heads of terms agreed with PropCo 1. Includes 37 Medicross pharmacies and 45 hospital retail pharmacy front shops 2. Subject to regulatory approvals

6 6 Group Financial overview 50% Revenue 50% 75% EBITDA 25% 94% Adjusted HEPS 6% South Africa United Kingdom Revenue R37 796m 12.1% EBITDA R5 539m 11.2% Adjusted HEPS cents 5.6% Final dividend 57.0 cents 5.6% Total dividend 95.0 cents 3.3%

7 SOUTH AFRICA

8 8 SA Healthcare network Hospitals Public Private Partnership hospitals Beds¹ Day clinics PHC² and sub-acutes Renal dialysis stations Netcare 911 sites Nursing and paramedic students 1. SA = ; Lesotho = PHC: Primary Healthcare Centres and travel clinics

9 9 SA Financials Rm 30 Sep Sep 2016 % Revenue EBITDA Operating profit EBITDA margin (%) Operating profit margin (%) Strong revenue performance driven by volume growth Margin pressure: + Cost inflation running ahead of price inflation + Higher growth in medical cases

10 10 SA Hospital and Emergency Services business update 4.7% patient days; + 2.8% H % H Full week occupancy of 67.2% % H % H new hospital beds including acquired umhlanga Eye Institute (21 beds) 164 specialists with practising privileges 1.6% shift in patient mix + Surgical 60.6% + Medical 39.4% 45 hospital retail pharmacy front shops to be outsourced to Clicks 1 February 2017

11 11 SA Hospital and Emergency Services Rm 30 Sep Sep 2016 % Revenue EBITDA Operating profit EBITDA margin (%) Operating profit margin (%) Note: EBITDA and operating profit are reflected before rental charges from Netcare property companies (eliminate on consolidation) + 2.4% patient days excluding Netcare Polokwane and Netcare Pinehaven + 5.2% revenue per patient day Negatively impacted by higher growth in medical cases + H margin 22.6% + depreciation arising from greenfield hospitals and brownfield beds added in 2015

12 12 SA Patient satisfaction and customer service External survey Netcare awarded Ask Afrika s Orange Index 1 st place in private hospital category and 6 th place overall across 33 industries Internal survey Patient experience: How many patients would recommend a Netcare hospital?¹ (%) Never or sometimes Usually Always surveys completed FY 2016

13 13 SA Netcare Christiaan Barnard Memorial Hospital Phase 1: 2016 Phase 2: Phase 3: Relocating to new site in December registered acute beds + 11 theatres and 2 cardiac catheterisation labs + A&E unit and first emergency helistop in Cape Town + Hybrid lease model Netcare to rent shell but responsible for fit-out + Medicross family medical and dental centre + Day clinic, 20 beds + Sub-acute facility, 36 beds + National Renal Care + Radiation and chemotherapy units + Conversion of 8 th floor parking and other open areas to provide an additional 96 acute beds Largest medical precinct in South Africa encompassing primary, secondary and tertiary facilities

14 14 SA New business pipeline HOSPITALS ONCOLOGY Netcare Akasia 9 beds + Netcare Kingsway 4 beds + Netcare Kuilsriver 22 beds + Netcare Margate 4 beds + Netcare Milpark 14 beds¹ + Netcare St Augustine s 10 beds Acquisition + Akeso Clinics² 10 mental health facilities 698 beds 2 greenfield facilities 175 beds + Gamma Knife - Netcare Milpark + Radiotherapy Netcare CBMH Netcare Montana Netcare Pinehaven Netcare Polokwane + Chemotherapy Netcare CBMH Netcare Milpark Netcare Montana Netcare Pinehaven 1. Transferring 110 beds and 5 theatres from Netcare Rand Hospital to Netcare Milpark hospital with 100 of these beds opening in Subject to regulatory approvals

15 15 SA Primary Care Rm 30 Sep Sep 2016 % Revenue EBITDA Operating profit EBITDA margin (%) Operating profit margin (%) Revenue impacted by fall in Prime Cure revenue as a result of strategy to downscale managed care division Higher margin due to termination of low margin contracts Sub-acute facilities acquired: + 16 beds in Pietermaritzburg + 20 beds in Amanzimtoti

16 16 SA Primary Care business update 37 retail pharmacies to be outsourced to Clicks as of 1 December 2016 Focus on expanding national network of day clinics and sub-acute facilities Day clinics: + Kimberley¹ + Upington + Richards Bay + Cape Town Sub-acute facilities: + Hillcrest + Cape Town + Richards Bay 1. Commenced operations mid October 2016

17 17 SA Regulatory update National Health Insurance (NHI) + Draft NHI White Paper published in December Davis Tax Committee called for submissions on funding of NHI in October Market awaits final White Paper Private Healthcare Market Inquiry (HMI) + Netcare made comprehensive submissions in 2014, 2015 and HMI yet to publish any position papers but a series of documents are expected during November and December HMI intends publishing revised timetable by 1 December 2016

18 UNITED KINGDOM

19 19 UK Hospital network Flagship hospital Large hospital 59 Hospitals¹ 196 Theatres London area Beds Employees hospitals, 3 clinics

20 Self-pay PMI 20 UK PMI and Self-pay PMI funder loss ratios² 1.8%¹ in PMI membership in 2015 but payouts to hospital providers remain in decline Insurance Premium Tax + Nov 2015: 9.5% + Nov 2016: 10.0% 80% 75% Increase in Self-pay elective procedures driven by growing NHS waiting lists Growth supported by packaged pricing and marketing initiatives 70% 65% Sector-wide shift towards day treatment and outpatient activity 60% Data for two large UK-based funders 1. Source: LaingBuisson, 4th edition, Source: Health Cover UK Market Report, LaingBuisson and published accounts

21 21 UK NHS Department of Health capital expenditure per financial year ( m)¹ (5.3%) CAGR NHS has seen significant funding constraints with insufficient investment in NHS estate Increased waiting lists and lower consumer confidence benefit private providers NHS admissions in independent sector hospitals² % CAGR bn forecast NHS funding gap by 2021 if no efficiency savings are achieved 1. Source: NHS England Five Year Forward View, the Health Foundation, Department of Health annual accounts 2. Source: Hospital Episode Statistics (NHS Digital)

22 22 UK NHS GP referrals to independent sector providers (rolling quarter) (>1 000 referrals) Sep 15 Dec 15 Mar 16 Jun 16 Sep 16 Ramsay BMI Spire Care Circle Nuffield Source: NHS England

23 23 UK Business update 3.2% overall activity 1.1% revenue 3.4% PMI caseload¹ 2.8% Self-pay caseload¹ Caseload¹ and EBITDA margin (%) 7.2% 7.1% 6.6% NHS caseload¹ 9.5% e-referral 3.7% outpatient activity Resilient margin performance notwithstanding payor mix 5.9% PMI Self-pay NHS e-referral NHS spot EBITDA margin² 1. Inpatient and day caseload 2. Excluding restructure costs, fair value gains and reversal of impairment on investment

24 24 UK BMI Healthcare (OpCo) m 30 Sep Sep 2016 % Revenue EBITDA (before items below) (0.3) Restructure costs (11.9) Fair value gain Reversal of impairment 2.0 EBITDA Operating profit EBITDA margin (%)¹ % inpatient and day caseload % is NHS funded caseload + GHG PropCo rent 148.5m (2015: 144.6m) + Other rent 12.2m (2015: 15.3m) + Shift in funder mix to NHS largely offset by efficiency benefits Reported EBITDA margin (%) Operating profit margin (%) Excluding restructure costs, fair value gains and reversal of impairment on investment

25 25 UK Capital investment New hybrid theatre and refurbishment at BMI The Alexandra Hospital New catheterisation lab and refurbishment at BMI The Park Hospital New endoscopy decontamination hubs in the north-west and south-east of England SPECT-CT at BMI The Clementine Churchill Hospital New 1.5T static MRI scanners at BMI Goring Hall Hospital, BMI The Beaumont Hospital and BMI Ridgeway Hospital

26 26 UK BMI Healthcare Quality Indicators 98.6% of patients are satisfied with the overall quality of care 99% of NHS patients would recommend BMI Healthcare to their family and friends Patient satisfaction with overall quality of care 97.2% 98.3% 98.6% BMI Shelburne and BMI Duchy hospitals are ranked number 1 & 2 Hospitals in the UK BMI is fully compliant with the Private Hospital Information Network (PHIN) data requirements All BMI hospitals fully compliant with CQC, HIS and HIW¹ CQC: Care Quality Commission; HIS: Healthcare Improvement Scotland; HIW: Healthcare Inspectorate Wales

27 FINANCIAL REVIEW

28 28 Group Financial overview Pleasing performance driven by new capacity added in 2015 Exceptional non-cash accounting charge on RPI¹ swaps Currency impact on Group asset base Strong balance sheet and comfortable gearing 1. RPI: Retail Price Index

29 29 Group Summarised statement of profit or loss Rm 30 Sep Sep 2016 % Revenue EBITDA Operating profit Net financial expenses (467) (433) Earnings of associates and JVs Normalised profit before taxation Normalised taxation (936) (966) Normalised profit for the year Exceptional items (1 858) Profit for the year GHG PropCo rent R3 124m (2015: R2 683m) + EBITDA margin 14.7% (2015: 14.8%) + Additional depreciation and finance charges from 2015 expansion programme + Effective tax rate 24.9% (2015: 27.7%) + Non-cash fair value RPI swap charge of R1 988m ( 107.9m) + Resultant tax credit of R130m ( 7.0m)

30 30 Group Constant currency performance Revenue (Rm) EBITDA (Rm) 5.5% % SA UK Exchange rate impact Average exchange rate of R21.04: 1 (2015: R18.55: 1) Closing exchange rate of R17.79: 1 (2015: R20.94: 1)

31 31 Group Headline earnings per share (HEPS) Rm 30 Sep Sep 2016 % Adjusted HEPS¹ (cents) HEPS (31.6) SA UK (6.3) (65.1) Adjusted HEPS¹ SA UK SA Group H1 H2 1. Adjusted to exclude Competition Commission costs, impairments, UK restructure costs, non-cash fair value adjustments on derivative financial instruments and changes in tax rates

32 32 Group Summarised statement of financial position Rm 30 Sep Sep 2016 Forex effect Other movement Assets PPE¹, goodwill and intangible assets (1 354) Other non-current assets (178) (100) Current assets (678) (225) Group capex R2 822m (2015: R2 653m) + SA: R2 054m (2015: R1 895m) + UK: R768m (2015: R758m) Total assets (2 210) Equity and liabilities Total shareholders equity (587) (685) Borrowings (528) (216) Other liabilities (1 095) Group net debt to EBITDA leverage 1.0 times (2015: 1.2 times) + Stable Group interest cover of 11.1 times (2015: 11.2 times) Total equity and liabilities (2 210) PPE: Property, Plant and Equipment

33 33 Group SA debt Rm 30 Sep Sep 2016 Gross debt Cash (1 345) (948) Facility utilisation (Rm) Net debt Net debt to EBITDA (times) Cost of debt (%) Net interest paid Interest cover (times) Cash outlay of R4 391m (2015: R4 432m) for capex, dividends and tax + Comfortable leverage ratio Utilised Cash Available + Capacity of DMTN programme increased to R7.5bn on 1 April % of debt at fixed interest rates

34 34 Group UK debt: BMI Healthcare m 30 Sep Sep 2016 Gross debt Facility utilisation ( m) 57.9 Cash (54.0) (57.9) Net debt Net debt to EBITDA (times)¹ Cost of debt² Net interest paid Debt term Utilised Cash Available + Repaid 23.1m maturing debt tranche in October Revolving credit facility maturity extended to March Comfortable gearing + Fully compliant with debt covenants 1. Excluding restructure costs and reversal of impairment on investment 2. Secured bank debt

35 35 Group UK rent transaction BMI has agreed heads of terms with its major external landlord for a potential rent transaction BMI in process of refinancing existing debt facilities, including funding for the rent transaction Rent transaction offers concrete value to BMI

36 GUIDANCE

37 37 Guidance SA outlook Resilient demand for private healthcare despite low growth in economy and formal employment Netcare participation in sizable medical scheme efficiency options effective 2017 will result in margin pressure Capital expenditure ±R1.7bn: + 49 new beds + Netcare CBMH and Netcare Milpark expansion + Oncology, day clinics and sub-acutes Acquisition¹ of Akeso Clinics, a national network of 12 mental health facilities 1. Subject to regulatory approvals

38 38 Guidance UK outlook Further opportunities for NHS growth Continued growth in Self-pay caseload expected Ongoing claims management and additional Insurance Premium Tax continue to weigh on PMI outlook Capital expenditure ± 44m

39 THANK YOU November 2016

40 APPENDICES

41 41 Appendix UK income statement segmental analysis m BMI Healthcare GHG PropCo 2¹ United Kingdom Revenue EBITDA (before GHG PropCo rent and items below) GHG PropCo rent (148.5) (148.5) EBITDA (before items below) Fair value gain Reversal of impairment EBITDA Operating profit Net financial expenses (16.5) (16.5) Earnings of associates and JVs Normalised profit before taxation Normalised taxation Normalised profit after taxation RPI swap fair value adjustment (net of tax) (100.9) (100.9) Profit/(loss) after taxation (85.6) 1.7 (83.9) 1. Comprising 6 hospital properties

42 42 Appendix Group borrowings at 30 September 2016 Gross borrowings Net borrowings Rm 30 Sep Sep Sep Sep 2016 SA BMI Healthcare Group Net debt to EBITDA (times) m BMI Healthcare Closing exchange rate

NETCARE LIMITED UNAUDITED INTERIM GROUP RESULTS FOR THE SIX MONTHS ENDED 31 MARCH 2016 CARE DIGNITY TRUTH PARTICIPATION PASSION

NETCARE LIMITED UNAUDITED INTERIM GROUP RESULTS FOR THE SIX MONTHS ENDED 31 MARCH 2016 CARE DIGNITY TRUTH PARTICIPATION PASSION NETCARE LIMITED UNAUDITED INTERIM GROUP RESULTS FOR THE SIX MONTHS ENDED 31 MARCH 2016 Group Overview South Africa United Kingdom Financial Review Guidance GROUP OVERVIEW 4 Group A comprehensive network

More information

Netcare Limited AUDITED GROUP RESULTS FOR THE YEAR ENDED 30 SEPTEMBER 2011

Netcare Limited AUDITED GROUP RESULTS FOR THE YEAR ENDED 30 SEPTEMBER 2011 Netcare Limited AUDITED GROUP RESULTS FOR THE YEAR ENDED 30 SEPTEMBER 2011 Agenda RICHARD FRIEDLAND GROUP CEO Group overview South Africa United Kingdom KEITH GIBSON GROUP CFO Financial review Guidance

More information

Netcare Limited UNAUDITED GROUP RESULTS FOR THE SIX MONTHS ENDED 31 MARCH 2012

Netcare Limited UNAUDITED GROUP RESULTS FOR THE SIX MONTHS ENDED 31 MARCH 2012 Netcare Limited UNAUDITED GROUP RESULTS FOR THE SIX MONTHS ENDED 31 MARCH 2012 1 RICHARD FRIEDLAND GROUP CEO Group overview South Africa United Kingdom KEITH GIBSON GROUP CFO Financial review Guidance

More information

Netcare Limited Interim results presentation For the six months ended 31 March 2008

Netcare Limited Interim results presentation For the six months ended 31 March 2008 1 Netcare Limited Interim results presentation For the six months ended 31 March 2008 Note regarding forward looking statements The Company advises investors that any forward looking statements or projections

More information

NETCARE LIMITED SUMMARISED AUDITED GROUP RESULTS

NETCARE LIMITED SUMMARISED AUDITED GROUP RESULTS SUMMARISED AUDITED GROUP RESULTS for the year ended 30 September 2017 01 contents02 Commentary 10 Declaration of final dividend 12 Group statement of profit or loss 13 Group statement of other comprehensive

More information

Living our values. Netcare Limited Audited Group Results. for the year ended 30 September 2008 CARE DIGNITY PARTICIPATION TRUTH PASSION

Living our values. Netcare Limited Audited Group Results. for the year ended 30 September 2008 CARE DIGNITY PARTICIPATION TRUTH PASSION CARE DIGNITY PARTICIPATION TRUTH PASSION Netcare Limited Audited Group Results for the year ended tember 2008 CARE DIGNITY PARTICIPATION TRUTH PASSION Note regarding forward looking statements The Company

More information

care helping for the health of humankind Netcare Limited 2014

care helping for the health of humankind Netcare Limited 2014 helping care for the health of humankind Netcare Limited 2014 AUDITED GROUP RESULTS for the year ended 30 September 2014 Contents Financial highlights 1 Commentary 2 Declaration of final dividend 9 Group

More information

Investing for the future: Spire

Investing for the future: Spire Investing for the future: Spire Healthcare Aslam Dalvi - Associate Portfolio Manager The UK public healthcare system has come under increasing pressure in recent times. An ageing population coupled with

More information

Financial Year Results Presentation

Financial Year Results Presentation 2016 Financial Year Results Presentation Disclaimer Important information: forward-looking statements These materials contain certain forward-looking statements relating to the business of Spire Healthcare

More information

Group Results and Cash Dividend Declaration Unaudited Group results for the six month period ended 31 March 2015

Group Results and Cash Dividend Declaration Unaudited Group results for the six month period ended 31 March 2015 www.lifehealthcare.co.za Group Results and Cash Dividend Declaration Unaudited Group results for the six month period ended 31 March 2015 Operational review André Meyer CEO 2 Highlights Group SA: 3.5%

More information

Acquisition of Capio UK 7 September 2007 Managing Director, Pat Grier

Acquisition of Capio UK 7 September 2007 Managing Director, Pat Grier Acquisition of Capio UK 7 September 2007 Managing Director, Pat Grier AGENDA 2 Executive Summary Why the UK Hospital Sector? Capio UK Business Overview Transaction Overview Financials Compelling Proposition

More information

Spire Healthcare. Interim results for the six months ended 30 June 2018

Spire Healthcare. Interim results for the six months ended 30 June 2018 Spire Healthcare Group plc Spire Healthcare Interim results for the six months ended 30 June 2018 London, UK, 18 September 2017, Spire Healthcare Group plc (LSE: SPI), one of the UK s leading independent

More information

2018 Half Year Results Presentation. 18 September 2018

2018 Half Year Results Presentation. 18 September 2018 2018 Half Year Results Presentation 18 September 2018 Disclaimer These materials contain certain forward-looking statements relating to the business of Spire Healthcare Group plc (the Company ), including

More information

2Q19 Results Presentation. 11 February 2019

2Q19 Results Presentation. 11 February 2019 2Q19 Results Presentation 11 February 2019 1 Disclaimer This is a presentation of general information relating to the current activities of the Health Management International Ltd ( HMI ). It is given

More information

NETCARE LIMITED 2017

NETCARE LIMITED 2017 NETCARE LIMITED ANNUAL FINANCIAL STATEMENTS 2017 contents ANNUAL FINANCIAL STATEMENTS 02 Directors' responsibility and approval 02 Certificate by the Company Secretary 03 Directors' report 10 Audit Committee

More information

Highlights of the Group s performance include:

Highlights of the Group s performance include: MEDIA RELEASE 21 November 2017 LIFE HEALTHCARE GROUP POSTS SOLID RESULTS POST ALLIANCE MEDICAL ACQUISITION Johannesburg, 21 November 2017: Life Healthcare Group Holdings Limited (JSE: LHC), one of South

More information

Looking to the medium term

Looking to the medium term Looking to the medium term Issued: 4 September 2013 Legal notice This presentation has been prepared to inform investors and prospective investors in the secondary markets about the Group and does not

More information

The Independent Hospital Sector. Jill Watts, CEO, Ramsay Health Care, UK Investing in Healthcare Conference 29 October 2008

The Independent Hospital Sector. Jill Watts, CEO, Ramsay Health Care, UK Investing in Healthcare Conference 29 October 2008 The Independent Hospital Sector Jill Watts, CEO, Ramsay Health Care, UK Investing in Healthcare Conference 29 October 2008 1 Agenda Overview of Ramsay Health Care The Independent Hospital Sector UK Market

More information

EMIS Group plc Full year results presentation 2017

EMIS Group plc Full year results presentation 2017 EMIS Group plc Full year results presentation 2017 Introduction Strong financial position with underlying growth despite one off costs Introduction Financial review Operational review Summary and outlook

More information

For personal use only

For personal use only ASX ANNOUNCEMENT 23 August 2012 RAMSAY HEALTH CARE REPORTS 14.5% RISE IN FULL YEAR CORE NET PROFIT Financial Highlights Core net profit 1 up 14.5% to $252.6 million Reported statutory net profit after

More information

Group UNAUDITED GROUP RESULTS FOR THE PERIOD ENDED 31 MARCH 2018,

Group UNAUDITED GROUP RESULTS FOR THE PERIOD ENDED 31 MARCH 2018, UNAUDITED GROUP RESULTS FOR THE PERIOD ENDED 31 MARCH 2018, SCRIP DISTRIBUTION WITH CASH DIVIDEND ALTERNATIVE, FURTHER CAUTIONARY AND TRADING STATEMENT Group LIFE HEALTHCARE UNAUDITED GROUP RESULTS 2018

More information

LIFE HEALTHCARE PRE-CLOSE INVESTOR CALL

LIFE HEALTHCARE PRE-CLOSE INVESTOR CALL LIFE HEALTHCARE PRE-CLOSE INVESTOR CALL SHREY VIRANNA - GROUP CEO PIETER VAN DER WESTHUIZEN - GROUP CFO 27 MARCH 2018 1 OUTLOOK AS PER ANNUAL RESULTS SHREY VIRANNA GROUP CEO 2 2018 Outlook FY Results Southern

More information

Briefing 25 February 2008 Financial Results Half Year ended 31 December 2007

Briefing 25 February 2008 Financial Results Half Year ended 31 December 2007 Briefing 25 February 2008 Financial Results Half Year ended 31 December 2007 AGENDA Ramsay Financial Performance Pre Capio UK ( Ramsay UK ) Ramsay Financial Performance Including Ramsay UK Operational

More information

FINANCIAL REVIEW INTRODUCTION. Jurgens Myburgh Chief Financial Officer

FINANCIAL REVIEW INTRODUCTION. Jurgens Myburgh Chief Financial Officer FINANCIAL REVIEW OUR COMMITMENT TO SHAREHOLDER VALUE IS MEASURED USING RETURNS ON INVESTED CAPITAL, THEREBY FOCUSING STRATEGIC DELIBERATIONS ON WAYS TO IMPROVE RETURNS ON THE GROUP S INVESTED ASSET BASE.

More information

PRESENTATION OUTLINE. Review of the period Financial results Trading performance Outlook Questions

PRESENTATION OUTLINE. Review of the period Financial results Trading performance Outlook Questions PRESENTATION OUTLINE Review of the period Financial results Trading performance Outlook Questions 2 REVIEW OF THE PERIOD DAVID KNEALE REVIEW OF THE PERIOD Strong health & beauty sales performance Increased

More information

For personal use only

For personal use only Ramsay Health Care Limited MACQUARIE SECURITIES AUSTRALIA CONFERENCE 2015 6 May 2015 Christopher Rex, Managing Director AGENDA 1. Ramsay Health Care Overview 2. Group Financial Highlights for the six months

More information

2017 FULL YEAR RESULTS PRESENTATION

2017 FULL YEAR RESULTS PRESENTATION 2017 FULL YEAR RESULTS PRESENTATION MEDICLINIC RESULTS DISCLAIMER This presentation contains certain forward-looking statements relating to the financial condition, the regulatory environment in which

More information

4Q18 Results Presentation. 27 August 2018

4Q18 Results Presentation. 27 August 2018 4Q18 Results Presentation 27 August 2018 1 Disclaimer This is a presentation of general information relating to the current activities of the Health Management International Ltd ( HMI ). It is given in

More information

MEDICLINIC INTERNATIONAL OVERVIEW PRESENTATION

MEDICLINIC INTERNATIONAL OVERVIEW PRESENTATION MEDICLINIC INTERNATIONAL OVERVIEW PRESENTATION J.P. MORGAN HEALTHCARE CONFERENCE 10 JANUARY 2018 DANIE MEINTJES CEO MEDICLINIC INTERNATIONAL PLC MEDICLINIC RESULTS DISCLAIMER This presentation contains

More information

PRELIMINARY REVIEWED CONDENSED CONSOLIDATED RESULTS FOR THE YEAR ENDED 31 AUGUST 2017

PRELIMINARY REVIEWED CONDENSED CONSOLIDATED RESULTS FOR THE YEAR ENDED 31 AUGUST 2017 PRELIMINARY REVIEWED CONDENSED CONSOLIDATED RESULTS FOR THE YEAR ENDED 31 AUGUST CONTENTS 1 Commentary 2 Consolidated statement of comprehensive income Group turnover up 10.9% 3 Consolidated statement

More information

Impact Healthcare REIT plc. Annual results for the period to 31 December 2017

Impact Healthcare REIT plc. Annual results for the period to 31 December 2017 Impact Healthcare REIT plc Annual results for the period to 31 December 2017 Agenda and presentation team Agenda Company overview The portfolio Key financials Enhancing the portfolio Our market Opportunities

More information

OECD Financial sustainability of healthcare systems Healthcare Productivity in the UK

OECD Financial sustainability of healthcare systems Healthcare Productivity in the UK OECD Financial sustainability of healthcare systems Healthcare Productivity in the UK Anita Charlesworth Chief Economist, Nuffield Trust 26 March 2013 This presentation covers: The budget outlook for publicly

More information

Spire Healthcare reports its results for the year ended 31 December 2017

Spire Healthcare reports its results for the year ended 31 December 2017 Spire Healthcare reports its results for the year ended 31 December 2017 London, UK, 2 March 2018, Spire Healthcare Group plc (LSE: SPI), one of the UK s leading independent hospital groups, today announces

More information

5th Annual Citi Australia and New Zealand Investment Conference London 10 March 2008 Pat Grier, Managing Director

5th Annual Citi Australia and New Zealand Investment Conference London 10 March 2008 Pat Grier, Managing Director 5th Annual Citi Australia and New Zealand Investment Conference London 10 March 2008 Pat Grier, Managing Director AGENDA About Ramsay Health Care The Reason for Ramsay s Success December 07 Half Year Results

More information

FY 2015 Results Presentation. 19 January 2016

FY 2015 Results Presentation. 19 January 2016 FY 2015 Results Presentation 19 January 2016 Disclaimer THIS PRESENTATION IS NOT AN OFFER OR SOLICITATION OF AN OFFER TO BUY OR SELL SECURITIES IN THE UNITED STATES OF AMERICA OR IN ANY OTHER JURISDICTION.

More information

Appendix 4.1 MEETING: Haringey Clinical Commissioning Group Governing Body Meeting DATE: Thursday, 15 March 2018 TITLE: LEAD DIRECTOR: AUTHOR: CONTACT DETAILS: Operating Plan: Timetable and Governance

More information

OVERVIEW 1H17 RESULTS

OVERVIEW 1H17 RESULTS CLICK 1H 2017 TO EDIT RESULTS MASTER TITLE 6 MONTHS ENDED 31 STYLE DECEMBER 2016 OVERVIEW 2 FINANCIAL SUMMARY Group Underlying Reported 1H 2017 1H 2016 1H 2017 1H 2016 Revenue 808.7 794.3 808.7 814.1 EBIT

More information

CLICKS GROUP LIMITED Registration number: 1996/000645/06 Share code: CLS ISIN: ZAE CUSIP: 18682W205

CLICKS GROUP LIMITED Registration number: 1996/000645/06 Share code: CLS ISIN: ZAE CUSIP: 18682W205 CLICKS GROUP LIMITED Registration number: 1996/000645/06 Share code: CLS ISIN: ZAE000134854 CUSIP: 18682W205 INTERIM CONDENSED CONSOLIDATED RESULTS FOR THE SIX MONTHS ENDED 28 FEBRUARY 2017 Group turnover

More information

Trust Board Meeting: Wednesday 13 November 2013 TB

Trust Board Meeting: Wednesday 13 November 2013 TB Trust Board Meeting: Wednesday 13 November 2013 Title Financial Performance to 30 September 2013 Status History For Information This is a regular report. Board Lead(s) Mr Mark Mansfield, Director of Finance

More information

2018 FULL YEAR RESULTS PRESENTATION

2018 FULL YEAR RESULTS PRESENTATION 2018 FULL YEAR RESULTS PRESENTATION MEDICLINIC RESULTS DISCLAIMER This presentation contains certain forward-looking statements relating to the financial condition, the regulatory environment in which

More information

RAMSAY HEALTH CARE REPORTS 23.6% RISE IN FULL YEAR CORE NET PROFIT

RAMSAY HEALTH CARE REPORTS 23.6% RISE IN FULL YEAR CORE NET PROFIT ASX ANNOUNCEMENT 25 August 2011 RAMSAY HEALTH CARE REPORTS 23.6% RISE IN FULL YEAR CORE NET PROFIT Financial Highlights Core net profit 1 after tax up 23.6% to $220.6 million Core EPS 2 up 19.6% to 101.1

More information

Audited Group Results for the year ended 30 September 2013 and cash dividend declaration

Audited Group Results for the year ended 30 September 2013 and cash dividend declaration Life Healthcare Group Holdings Limited Registration number: 2003/002733/06 Income tax number: 9387/307/15/1 ISIN: ZAE000145892 Share code: LHC Audited Group Results for the year ended 30 September 2013

More information

NHS GRAMPIAN. Asset Management Plan. The Board is asked to consider and approve the Asset Management Plan.

NHS GRAMPIAN. Asset Management Plan. The Board is asked to consider and approve the Asset Management Plan. NHS GRAMPIAN Board Meeting 01.06.17 Open Session Item 10 Asset Management Plan 1. Actions Recommended The Board is asked to consider and approve the Asset Management Plan. 2. Strategic Context The Scottish

More information

Corporate Performance Report 2013/14

Corporate Performance Report 2013/14 BoD/04/14 Corporate Performance Report 2013/14 December 2013 OUR VISION: OUR MISSION: To be known as one of the top ten hospital Trusts in England and the Kent hospital of choice for patients and those

More information

SUMMA HEALTH SYSTEM OBLIGATED GROUP CONTINUING DISCLOSURE FOR THE THREE MONTHS ENDED MARCH 31, 2012

SUMMA HEALTH SYSTEM OBLIGATED GROUP CONTINUING DISCLOSURE FOR THE THREE MONTHS ENDED MARCH 31, 2012 SUMMA HEALTH SYSTEM OBLIGATED GROUP CONTINUING DISCLOSURE FOR THE THREE MONTHS ENDED MARCH 31, 2012 MANAGEMENT S DISCUSSION AND ANALYSIS OF THE RESULTS OF OPERATIONS AND FINANCIAL POSITION SUMMA HEALTH

More information

Interim FY 2015 results 6 months ended 31 December February 2015

Interim FY 2015 results 6 months ended 31 December February 2015 Interim FY 2015 results 31 December 2014 18 February 2015 Highlights Solid trading result for 1H FY2015; change in accounting policy for acquisition of healthcare practices First half result highlights

More information

1H18 results. Dr. Ian Kadish (MD & CEO) Anne Lockwood (CFO) 19 January 2018

1H18 results. Dr. Ian Kadish (MD & CEO) Anne Lockwood (CFO) 19 January 2018 1H18 results Dr. Ian Kadish (MD & CEO) Anne Lockwood (CFO) 19 January 2018 Today s presenters Dr. Ian Kadish Managing Director and Chief Executive Officer Joined Integral Diagnostics in May 2017 Has held

More information

BOARD OF DIRECTORS COVER SHEET PART 1. DATE: 30 January Subject: CHARITABLE FUNDS EXPENDITURE OVER 25,000

BOARD OF DIRECTORS COVER SHEET PART 1. DATE: 30 January Subject: CHARITABLE FUNDS EXPENDITURE OVER 25,000 BOARD OF DIRECTORS COVER SHEET PART 1 DATE: 3 January 219 Agenda item: 11 Paper: F Subject: CHARITABLE FUNDS EXPENDITURE OVER 25, Prepared by: Presented by: Purpose of paper Background Key points for Board

More information

Responsible investment in growth

Responsible investment in growth Responsible investment in growth Issued: 1 March 2016 Legal notice This presentation has been prepared to inform investors and prospective investors in the secondary markets about the Group and does not

More information

Genesis HealthCare. A Leading National Provider of Post-Acute Services. August 2015

Genesis HealthCare. A Leading National Provider of Post-Acute Services. August 2015 Genesis HealthCare A Leading National Provider of Post-Acute Services August 2015 Safe Harbor Statement Certain statements in this presentation regarding the expected benefits of the Skilled Healthcare

More information

TRELLIDOR HOLDINGS LIMITED AUDITED RESULTS FOR THE YEAR ENDED 30 JUNE 2016

TRELLIDOR HOLDINGS LIMITED AUDITED RESULTS FOR THE YEAR ENDED 30 JUNE 2016 TRELLIDOR HOLDINGS LIMITED AUDITED RESULTS FOR THE YEAR ENDED 30 JUNE 2016 OVERVIEW Trellidor is the market leading manufacturer of custom made barrier security products Distribution through dedicated

More information

Foxtons Preliminary results presentation For the year ended December 2018

Foxtons Preliminary results presentation For the year ended December 2018 Foxtons Preliminary results presentation For the year ended December 2018 Important information This presentation includes statements that are, or may be deemed to be, forward-looking statements. These

More information

FINANCIAL REVIEW UNDERLYING NON-IFRS FINANCIAL MEASURES 14 MEDICLINIC ANNUAL REPORT 2017 FINANCIAL REVIEW

FINANCIAL REVIEW UNDERLYING NON-IFRS FINANCIAL MEASURES 14 MEDICLINIC ANNUAL REPORT 2017 FINANCIAL REVIEW 14 MEDICLINIC ANNUAL REPORT 2017 FINANCIAL REVIEW FINANCIAL REVIEW UNDERLYING NON-IFRS FINANCIAL MEASURES Jurgens Myburgh Chief Financial Officer The Group uses underlying income statement reporting as

More information

Forward Looking Statements

Forward Looking Statements MLP Care 1Q2018 Presentation 8 May 2018 Forward Looking Statements This presentation may contain certain forward-looking statements concerning MLP Care s future performance and should be considered as

More information

1H18 RESULTS 6 MONTHS ENDED 31 DECEMBER 2017

1H18 RESULTS 6 MONTHS ENDED 31 DECEMBER 2017 1H18 RESULTS 6 MONTHS ENDED 31 DECEMBER 2017 GROUP RESULTS 2 GROWTH IN PROFIT AND FCF Group Underlying 1 Reported 2 1H 2018 1H 2017 1H 2018 1H 2017 Revenue 856.5 808.7 856.5 808.7 EBIT 81.3 81.9 61.6 61.1

More information

NHS Planning Guidance 2016/ /21

NHS Planning Guidance 2016/ /21 NHS Planning Guidance 2016/17 2020/21 Trust Board Meeting Item: 13 Date: 27 th January 2016 Purpose of the Report: Enclosure: I1 To provide the Board with a summary of the NHS Annual Planning Guidance

More information

2017/18 INTERIM RESULTS PRESENTATION

2017/18 INTERIM RESULTS PRESENTATION 2017/18 INTERIM RESULTS PRESENTATION MEDICLINIC RESULTS DISCLAIMER This presentation contains certain forward-looking statements relating to the financial condition, the regulatory environment in which

More information

MTN Group Limited Results presentation for the six months ended 30 June 2017

MTN Group Limited Results presentation for the six months ended 30 June 2017 MTN Group Limited Results presentation for the six months ended 30 June 2017 Disclaimer The information contained in this document has not been verified independently. No representation or warranty express

More information

IDH Finance plc Quarterly Financial Report 3 months ended 30 June 2016

IDH Finance plc Quarterly Financial Report 3 months ended 30 June 2016 IDH Finance plc Quarterly Financial Report 3 months ended 30 June 2016 1 IDH Finance plc Q1 2017 Contents Summary highlights 4 Management s discussion and analysis of financial condition and results of

More information

Corporate Performance Report 2015/16

Corporate Performance Report 2015/16 Bod/76/15 Corporate Performance Report 2015/16 May 2015 OUR VISION: OUR MISSION: To be known as one of the top ten hospital Trusts in England and the Kent hospital of choice for patients and those close

More information

ANNUAL RESULTS FOR THE YEAR ENDED 31 AUGUST 2017

ANNUAL RESULTS FOR THE YEAR ENDED 31 AUGUST 2017 ANNUAL RESULTS FOR THE YEAR ENDED 31 AUGUST 2017 PRESENTATION OUTLINE Review of the year Financial results Trading performance Outlook Questions 2 REVIEW OF THE YEAR DAVID KNEALE REVIEW OF THE YEAR Strong

More information

Responsible investment in growth

Responsible investment in growth Responsible investment in growth Issued: 17 June 2014 Legal notice This presentation has been prepared to inform investors and prospective investors in the secondary markets about the Group and does not

More information

Annual Results. 12 months ended 28 February Agenda

Annual Results. 12 months ended 28 February Agenda Annual Results 28 ruary 2015 Bridging y expectations Agenda 2015 2014 2 1 12 month overview Phase 1 of turnaround strategy successfully implemented Closed-out problem contracts Closed non-performing Power

More information

MLP Care Analyst Meeting Liv Hospital Ulus, March 7 th 2018

MLP Care Analyst Meeting Liv Hospital Ulus, March 7 th 2018 MLP Care Analyst Meeting Liv Hospital Ulus, March 7 th 2018 MLP Overview Dr. Muharrem Usta Chairman and CEO 2 Summary Results above our expectations Growth across all segments Double digit growth in Net

More information

SUMMARISED AUDITED GROUP RESULTS

SUMMARISED AUDITED GROUP RESULTS SUMMARISED AUDITED GROUP RESULTS OF MEDICLINIC INTERNATIONAL LIMITED AND ITS SUBSIDIARIES FOR THE YEAR ENDED 31 MARCH AND DECLARATION OF CASH DIVIDEND Incorporated in the Republic of South Africa Registration

More information

FY19 half year results

FY19 half year results FY19 half year results For the six months ended 31 December 2018 14 February 2019 Gordon Ballantyne Managing Director & Chief Executive Officer Michael Sammells Chief Financial Officer 1 1HFY19 returned

More information

For personal use only 1H 2016 RESULTS 6 M O N T H S E N D E D 3 1 D E C E M B E R

For personal use only 1H 2016 RESULTS 6 M O N T H S E N D E D 3 1 D E C E M B E R 1H 2016 RESULTS 6 M O N T H S E N D E D 3 1 D E C E M B E R 2 0 1 5 17 FEBRUARY 2016 OVERVIEW 1H 2016 Underlying result in line with expectations Reported results strong supported by one-offs Strengthened

More information

2015/16 Financial Position (Month 2) Author: Lorraine Bentley Sponsor: Paul Traynor Date: Trust Board - Thursday 2 nd July 2015

2015/16 Financial Position (Month 2) Author: Lorraine Bentley Sponsor: Paul Traynor Date: Trust Board - Thursday 2 nd July 2015 U N I V E R S I T Y H O S P I T A L S O F L E I C E S T E R N H S T R U S T P A G E 1 O F 2 2015/16 Financial Position (Month 2) Author: Lorraine Bentley Sponsor: Paul Traynor Date: Trust Board - Thursday

More information

For personal use only

For personal use only Financial and Operational Review For the year ended 30 June 2017 Colin Goldschmidt CEO, Sonic Healthcare 16 August 2017 Forward-looking statements This presentation may include forward-looking statements

More information

A leading provider of post acute services

A leading provider of post acute services A leading provider of post acute services November 2018 2018 by Genesis Healthcare, Inc. All Rights Reserved. Safe Harbor Statement Certain statements in this presentation regarding the expected benefits

More information

Removing private practice from public hospitals: Submission of the Health Insurance Authority to the de Buitleir Independent Review Group

Removing private practice from public hospitals: Submission of the Health Insurance Authority to the de Buitleir Independent Review Group Removing private practice from public hospitals: Submission of the Health Insurance Authority to the de Buitleir Independent Review Group February 2018 The Health Insurance Authority welcomes the invitation

More information

Integrated Dental Holdings. Q4 FY2017 Year-end and Quarterly Results - Investor presentation 1 June 2017

Integrated Dental Holdings. Q4 FY2017 Year-end and Quarterly Results - Investor presentation 1 June 2017 Integrated Dental Holdings Q4 FY2017 Year-end and Quarterly Results - Investor presentation 1 June 2017 DISCLAIMER THIS PRESENTATION IS NOT AN OFFER OR SOLICITATION OF AN OFFER TO BUY OR SELL SECURITIES

More information

Availability, Reliability, Ease. 11 December 2018

Availability, Reliability, Ease. 11 December 2018 Availability, Reliability, Ease 11 December 2018 LEGAL NOTICE This presentation has been prepared to inform investors and prospective investors in the secondary markets about the Group and does not constitute

More information

Availability, Reliability, Ease. 11 September 2018

Availability, Reliability, Ease. 11 September 2018 Availability, Reliability, Ease 11 September 2018 LEGAL NOTICE This presentation has been prepared to inform investors and prospective investors in the secondary markets about the Group and does not constitute

More information

Investor pre-close briefing. 15 September

Investor pre-close briefing. 15 September Investor pre-close briefing 15 September Proviso Please note that matters discussed in today s presentation may contain forward looking statements which are subject to various risks and uncertainties and

More information

HALF YEAR RESULTS PRESENTATION

HALF YEAR RESULTS PRESENTATION HALF YEAR RESULTS PRESENTATION 6 MONTHS ENDED 30 JUNE 2013 7 August 2013 1 www.bupa.com AGENDA 1.0 Introduction and Highlights Stuart Fletcher, Chief Executive Officer 2.0 Financial Review Evelyn Bourke,

More information

Trust Board Meeting: Wednesday 8 July 2015 TB Title Financial Performance to 31 May 2015

Trust Board Meeting: Wednesday 8 July 2015 TB Title Financial Performance to 31 May 2015 Trust Board Meeting: Wednesday 8 July 2015 Title Financial Performance to 31 May 2015 Status History A paper for report. Regular report Board Lead Mr Mark Mansfield, Director of Finance and Procurement

More information

SUMMARISED CONSOLIDATED RESULTS FOR THE YEAR ENDED 30 SEPTEMBER 2018, AND CASH DIVIDEND DECLARATION. Group

SUMMARISED CONSOLIDATED RESULTS FOR THE YEAR ENDED 30 SEPTEMBER 2018, AND CASH DIVIDEND DECLARATION. Group SUMMARISED CONSOLIDATED RESULTS FOR THE YEAR ENDED 30 SEPTEMBER 2018, AND CASH DIVIDEND DECLARATION Group LIFE HEALTHCARE SUMMARISED CONSOLIDATED RESULTS 2018 Highlights Revenue +12.9% to R23.5 billion

More information

Quarterly Strategy Note January 2017

Quarterly Strategy Note January 2017 Neil Brown & Richard Hasson Co-Heads Quarterly Strategy Note January 2017 THE SOUTH AFRICAN PRIVATE SECTOR HOSPITAL INDUSTRY AND ITS LISTED COMPANIES WILL THEY RECOVER OR IS IT TERMINAL? by Neil Brown

More information

A Leading National Provider of Post-Acute Services

A Leading National Provider of Post-Acute Services A Leading National Provider of Post-Acute Services February 2016 Safe Harbor Statement Certain statements in this presentation regarding the expected benefits of the Skilled Healthcare transaction, future

More information

2015 Nursing Conference College of Nursing, Hong Kong

2015 Nursing Conference College of Nursing, Hong Kong 2015 Nursing Conference College of Nursing, Hong Kong Voluntary Health Insurance Scheme (VHIS) Food and Health Bureau 8 February 2015 Dr KO Wing Man, BBS, JP Secretary for Food & Health Hong Kong SAR Government

More information

TRELLIDOR HOLDINGS LIMITED UNAUDITED INTERIM RESULTS FOR THE SIX MONTHS ENDED 31 DECEMBER 2017

TRELLIDOR HOLDINGS LIMITED UNAUDITED INTERIM RESULTS FOR THE SIX MONTHS ENDED 31 DECEMBER 2017 TRELLIDOR HOLDINGS LIMITED UNAUDITED INTERIM RESULTS FOR THE SIX MONTHS ENDED 31 DECEMBER 2017 GROUP HIGHLIGHTS 5% Revenue 5% PAT 5% HEPS 35.2c 5% Interim dividend declared 11.0 cents per share Slide 2

More information

2015/16 Financial Position to Month 1 - April. Author: [Lorraine Bentley] Sponsor: [Paul Traynor] Date: [Thursday 4 June 2015]

2015/16 Financial Position to Month 1 - April. Author: [Lorraine Bentley] Sponsor: [Paul Traynor] Date: [Thursday 4 June 2015] U N I V E R S I T Y H O S P I T A L S O F L E I C E S T E R N H S T R U S T P A G E 1 O F 2 2015/16 Financial Position to Month 1 - April Author: [Lorraine Bentley] Sponsor: [Paul Traynor] Date: [Thursday

More information

SUMMARISED CONSOLIDATED RESULTS For the year ended 30 June 2016 STRATEGIC & OPERATIONAL OVERVIEW. Canal Walk (Cape Town, Western Cape)

SUMMARISED CONSOLIDATED RESULTS For the year ended 30 June 2016 STRATEGIC & OPERATIONAL OVERVIEW. Canal Walk (Cape Town, Western Cape) SUMMARISED CONSOLIDATED RESULTS For the year ended 30 June 2016 STRATEGIC & OPERATIONAL OVERVIEW Canal Walk (Cape Town, Western Cape) 1 STRATEGY & OVERVIEW South African REIT Focused on emerging markets

More information

NHS Operating Framework Key point summary, Page 1

NHS Operating Framework Key point summary, Page 1 NORTH EAST AMBULANCE SERVICE NHS TRUST OPERATING FRAMEWORK FOR THE NHS IN ENGLAND : 2010-11 SUMMARY OF KEY POINTS REPORT BY: DIRECTOR OF STRATEGY & BUSINESS DEVELOPMENT Forward Focus on Quality changes

More information

Interim Results. Six months ended 31 August 2016

Interim Results. Six months ended 31 August 2016 Interim Results Six months ended 31 August 2016 Stefanutti Stocks City A multi-disciplinary construction group (Vision) (Mission) 2 www.stefanuttistocks.com y 2 Agenda Six month overview Operational Overview

More information

A Leading National Provider of Post-Acute Services

A Leading National Provider of Post-Acute Services A Leading National Provider of Post-Acute Services November 2015 Safe Harbor Statement Certain statements in this presentation regarding the expected benefits of the Skilled Healthcare transaction, future

More information

SOUTHERN AFRICA CONTINUED

SOUTHERN AFRICA CONTINUED SOUTHERN AFRICA CONTINUED CHAIRMAN S REPORT Edwin Hertzog Non-executive Chairman OUR RELENTLESS FOCUS ON PATIENT NEEDS SHOULD CONTINUE TO CREATE LONG-TERM SHAREHOLDER VALUE AND ENTRENCH MEDICLINIC INTERNATIONAL

More information

Growth and diversification. 7 March 2017

Growth and diversification. 7 March 2017 Growth and diversification 7 March 2017 LEGAL NOTICE 2 This presentation has been prepared to inform investors and prospective investors in the secondary markets about the Group and does not constitute

More information

Cleopatra Hospitals Group Reports FY2017 Results

Cleopatra Hospitals Group Reports FY2017 Results Cleopatra Hospitals Group Reports FY2017 Results 4Q2017 Financial and Operational Highlights 1 FY2017 Financial and Operational Highlights EGP 310 million Total Consolidated Revenue (+30% y-o-y) EGP 75

More information

The 2014/15 year to date (YTD) revenue position for GYW CCG is 1,565k surplus which is to plan.

The 2014/15 year to date (YTD) revenue position for GYW CCG is 1,565k surplus which is to plan. Governing Body Meeting 27 November 2014 Agenda Item 17 Title of paper What the Committee is being asked to decide or approve Great Yarmouth & Waveney Clinical Commissioning Group Finance & QIPP Report

More information

The Royal Wolverhampton NHS Trust

The Royal Wolverhampton NHS Trust The Royal Wolverhampton NHS Trust Trust Board Meeting Date: 25 April 2016 Title: Income and Expenditure Plan for 2016/17 Executive Summary: Action Requested: This report details the proposed Income & Expenditure

More information

CWM TAF UNIVERSITY HEALTH BOARD MINUTES OF THE MEETING OF THE AUDIT COMMITTEE HELD ON 3 JUNE 2015 AT YNYSMEURIG HOUSE, ABERCYNON

CWM TAF UNIVERSITY HEALTH BOARD MINUTES OF THE MEETING OF THE AUDIT COMMITTEE HELD ON 3 JUNE 2015 AT YNYSMEURIG HOUSE, ABERCYNON CWM TAF UNIVERSITY HEALTH BOARD MINUTES OF THE MEETING OF THE AUDIT COMMITTEE HELD ON 3 JUNE 2015 AT YNYSMEURIG HOUSE, ABERCYNON PRESENT Mr G Bell - Independent Member (Chair) Mr M Forey - Independent

More information

2017/18 Financial Plan and Budgets. John Ingham, Chief Finance Officer, NHS Norwich CCG. Discussion and Approval

2017/18 Financial Plan and Budgets. John Ingham, Chief Finance Officer, NHS Norwich CCG. Discussion and Approval Agenda Item: 13 NHS Norwich CCG Governing Body Tuesday 28 th March 2017 Subject: Presented By: 2017/18 Financial Plan and Budgets John Ingham, Chief Finance Officer, NHS Norwich CCG Submitted To: NHS Norwich

More information

Annual Financial Plan 2018/19. April 2018

Annual Financial Plan 2018/19. April 2018 Annual Financial Plan April 2018 1 Progress to date Assumptions Bridge from 2017/18 to Draft I&E Summary CIPs Cash Capital plan Risks Contents 2 Progress from Draft March plan to final submission The Trust

More information

SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST EXECUTIVE SUMMARY REPORT TO THE BOARD OF DIRECTORS 21 FEBRUARY 2018

SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST EXECUTIVE SUMMARY REPORT TO THE BOARD OF DIRECTORS 21 FEBRUARY 2018 SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST EXECUTIVE SUMMARY D REPORT TO THE BOARD OF DIRECTORS 21 FEBRUARY 2018 Subject: NHS Planning Guidance 2018-19 Supporting TEG Member: Authors: Status Neil

More information

B e n e f i t O p t i o n s

B e n e f i t O p t i o n s 2018 Benefit Options 2018 What determines your decision to join a medical aid? At Selfmed we cut straight to the Is it the add-on s, you know the free gym membership and movie tickets or, is it the reliable

More information

A leading provider of post acute services

A leading provider of post acute services A leading provider of post acute services March 2018 2018 by Genesis Healthcare, Inc. All Rights Reserved. Safe Harbor Statement Certain statements in this presentation regarding the expected benefits

More information

Investor pre-close briefing. 14 March

Investor pre-close briefing. 14 March Investor pre-close briefing 14 March Proviso Please note that matters discussed in today s presentation may contain forward looking statements which are subject to various risks and uncertainties and other

More information

INVESTOR PRESENTATION. For the 53 week period ended 30 December 2016

INVESTOR PRESENTATION. For the 53 week period ended 30 December 2016 INVESTOR PRESENTATION For the 53 week period ended 30 December 2016 Trading update 53 week period ended 30 December 2016 52 week period ended 25 December 2015 Increase/ (decrease) (per cent) Revenue (

More information